Patents by Inventor James Ford Burns

James Ford Burns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same
    Publication number: 20170217950
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: April 18, 2017
    Publication date: August 3, 2017
    Applicant: H. Lundbeck A/S
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • Bicyclo[3.2.1]octyl amide derivatives and uses of same
    Patent number: 9656975
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Grant
    Filed: November 4, 2014
    Date of Patent: May 23, 2017
    Assignee: H. Lundbeck A/S
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • BICYCLO[3.2.1.]OCTYL AMIDE DERIVATIVES AND USES OF SAME
    Publication number: 20150057289
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: November 4, 2014
    Publication date: February 26, 2015
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • Bicyclo[3.2.1]octyl amide derivatives and uses of same
    Patent number: 8921370
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: December 30, 2014
    Assignee: H. Lundbeck A/S
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME
    Publication number: 20120190686
    Abstract: The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: December 22, 2011
    Publication date: July 26, 2012
    Applicant: H. LUNDBECK A/S
    Inventors: Guiying Li, Hao Zhou, Jesse Weiss, Dario Doller, James Ford Burns
  • AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS
    Publication number: 20120101078
    Abstract: Disclosed are a series of neuropeptide Y Y5 receptor ligands, and as such are useful to treat disorders related to mood, stress, ADHD, cognition, stress and dementia.
    Type: Application
    Filed: March 19, 2010
    Publication date: April 26, 2012
    Applicant: H. Lundbrck A/S
    Inventors: Bin Chen, James Ford Burns, Dario Doller
  • Peptidase inhibitors
    Patent number: 7842707
    Abstract: The present invention relates to a series of novel compounds having the formula (I) wherein: X is NR3 or O; n is 1 or 2; A is a bicyclic carbocycle and R1 and R2 are as described herein. The compounds are useful as DPP-IV inhibitors, such as for the treatment of diabetes.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: November 30, 2010
    Assignee: Nuada, LLC
    Inventors: Susan Marie Royalty, James Ford Burns, Jan Jozef Scicinski, Gunnar Erik Jagdmann, Jr., Robert James Foglesong, Kellee Griffin Ring, Tatyana Dyakonov, David Middlemiss
  • Peptidase Inhibitors
    Publication number: 20080234292
    Abstract: The present invention relates to a series of novel compounds having the formula (I) wherein: X is NR3 or O; n is 1 or 2; A is a bicyclic carbocycle and R1 and R2 are as described herein. The compounds are useful as DPP-IV inhibitors, such as for the treatment of diabetes.
    Type: Application
    Filed: July 21, 2005
    Publication date: September 25, 2008
    Inventors: Susan Marie Royalty, James Ford Burns, Jan Jozef Scicinski, Gunnar Erik Jagdmann, Jr., Robert James Foglesong, Kellee Griffin Ring, Tatyana Dyakonov, David Middlemiss